HALOZYME THERAPEUTICS INC. - US40637H1095 (Stock)
Düsseldorf
| Price | Diff.% | Date & Time | Bid volume | Bid | Ask | Ask volume |
|---|---|---|---|---|---|---|
49,88 EUR
|
1,0944% | 25.07.2025 08:11 | 230,00 | 49,75 | 50,12 | 230,00 |
| Balance ratios | 2023 | 2022 |
|---|---|---|
| Total assets | - | - |
| Employees | - | - |
| Cash and cash equivalents | - | - |
| Intangible / inalienable assets | - | - |
| Economic shareholder's equity | - | - |
| Subscribed Capital | - | - |
| Liabilities | - | - |
| Liabilities to financial institutions | - | - |
| GuV Zahlen | 2023 | 2022 |
|---|---|---|
| Sales | - | - |
| Profit after tax | - | - |
| Deprecation (??) | - | - |
| Dividend ordinary shares | - | - |
| Net investment income | - | - |
| Dividend preferred shares | - | - |
| Net interests income | - | - |
| Earnings from ordinary operating activities | - | - |
| Net income (after minority interests) | - | - |
| Net earnings per share | - | - |
| Total payout | - | - |
| Administrative expenses | - | - |
© 2000 - 2025 UniCredit Bank Austria AG. Please read our terms and conditions
Implemented and powered by FactSet
Fond data is provided from Mountain-View Data Gmbh
Austria-HomePage Version 2.0.54
